Taken together, we could conclude that the inhibitory impact of FASN on ferroptosis was achieved via NF-κB/STAT3/GPX4 axis, thereby facilitating tumor growth and resistance to ADM in DLBCL. The gene discussed is GPX4; the disease is diffuse large B-cell lymphoma.